9 Meters Biopharma (NMTRQ) 10-Q 21 Aug 17 2017 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2017	Jul. 31, 2017
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Entity Registrant Name	Monster Digital, Inc.
Entity Central Index Key	1,551,986
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	MSDI
Entity Common Stock, Shares Outstanding		9,343,202

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets
Cash	$ 39	$ 1,453
Accounts receivable, net of allowances of $271 and $253, respectively	214	856
Inventories	607	1,105
Prepaid expenses and other	325	619
Total current assets	1,185	4,033
Trademark, net of amortization of $251 and $185, respectively	2,351	2,417
Deposits and other assets	14	14
Total assets	3,550	6,464
Current liabilities
Accounts payable	599	268
Accrued expenses	1,416	1,786
Customer refund	1,336	1,840
Due to related parties	34	44
Notes payable	378	38
Total current liabilities	3,763	3,976
Commitments and contingencies
Shareholders’ (deficit) equity
Preferred stock; 10,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $.0001 par value; 100,000,000 shares authorized; 9,343,202 and 7,785,011 shares issued and outstanding, respectively	1	1
Additional paid-in capital	35,753	34,575
Accumulated deficit	(35,967)	(32,088)
Total shareholders’ (deficit) equity	(213)	2,488
Total liabilities and shareholders’ (deficit) equity	$ 3,550	$ 6,464

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Allowance for Doubtful Accounts Receivable, Current	$ 271	$ 253
Finite-Lived Intangible Assets, Accumulated Amortization	$ 251	$ 185
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	9,343,202	7,785,011
Common Stock, Shares, Outstanding	9,343,202	7,785,011

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Net sales	$ 187	$ 1,683	$ 1,138	$ 2,220
Cost of goods sold	226	1,253	1,224	1,743
Gross profit (loss)	(39)	430	(86)	477
Operating expenses
Research and development	81	65	150	114
Selling and marketing	327	591	1,027	1,227
General and administrative	1,191	675	2,683	1,470
Total operating expenses	1,599	1,331	3,860	2,811
Operating loss	(1,638)	(901)	(3,946)	(2,334)
Other (income) expense, net
Interest and finance expense	0	339	1	787
Gain on settlement of customer refund	0	0	(68)	0
Total other (income) expense	0	339	(67)	787
Loss before income taxes	(1,638)	(1,240)	(3,879)	(3,121)
Provision for income taxes	0	0	0	0
Net Loss	$ (1,638)	$ (1,240)	$ (3,879)	$ (3,121)
Loss Per Share
Basic and Diluted	$ (0.19)	$ (0.33)	$ (0.47)	$ (0.83)
Number of Shares used in Computation
Basic and Diluted	8,446	3,750	8,323	3,749

CONSOLIDATED STATEMENT OF SHARE

CONSOLIDATED STATEMENT OF SHAREHOLDERS’ (DEFICIT) EQUITY - 6 months ended Jun. 30, 2017 - USD ($) $ in Thousands	Total	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2016	$ 2,488	$ 1	$ 0	$ 34,575	$ (32,088)
Balance (in shares) at Dec. 31, 2016		7,785,011	0
Issuance of common stock, net of issuance costs	419	$ 0	$ 0	419	0
Issuance of common stock, net of issuance costs (in shares)		469,478	0
Issuance of common stock pursuant to stock option plan	0	$ 0	$ 0	0	0
Issuance of common stock pursuant to stock option plan (in shares)		795,610	0
Issuance of common stock pursuant to consulting arrangements	0	$ 0	$ 0	0	0
Issuance of common stock pursuant to consulting arrangements (in shares)		82,500	0
Warrant exercise	0	$ 0	$ 0	0	0
Warrant exercise (in shares)		38,189	0
Conversion of related party debt into equity	100	$ 0	$ 0	100	0
Conversion of related party debt into equity (in shares)		172,414	0
Amortization of non-cash stock-based compensation	659	$ 0	$ 0	659	0
Net loss	(3,879)	0	0	0	(3,879)
Balance at Jun. 30, 2017	$ (213)	$ 1	$ 0	$ 35,753	$ (35,967)
Balance (in shares) at Jun. 30, 2017		9,343,202	0

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities
Net loss	$ (3,879)	$ (3,121)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	659	179
Amortization of deferred debt issuance costs and debt discount	0	691
Amortization of trademark	66	65
Gain on settlement of customer refund	(68)	0
Provision for doubtful accounts	20	119
Changes in operating assets and liabilities:
Accounts receivable	622	(513)
Inventories	498	(396)
Prepaid expenses and other	294	87
Accounts payable	331	445
Accrued expenses	(302)	317
Customer refund	(504)	(25)
Due to related parties	(10)	0
Net cash used in operating activities	(2,273)	(2,152)
Cash flows from financing activities
Proceeds from issuance of preferred stock, net	0	2,393
Issuance of common stock, net of issuance cost	419	0
Proceeds from issuance of convertible notes	340	0
Short-term loan - related party	100	24
Proceeds from issuance of bridge financing	0	406
Payments on trademark note payable	0	(75)
Proceeds from credit facility	0	581
Payments on credit facility	0	(474)
Prepaid IPO costs	0	(613)
Deferred financing costs	0	(57)
Net cash provided by financing activities	859	2,185
Net (decrease) increase in cash	(1,414)	33
Cash, beginning of the period	1,453	119
Cash, end of the period	39	152
Cash paid during the period for:
Interest	1	29
Non-cash investing and financing activities:
Conversion of related party debt into equity	100	0
Deferred IPO costs	$ 0	$ 356

BUSINESS ACTIVITY AND SUMMARY O

BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Basis of Presentation and Significant Accounting Policies [Text Block]	NOTE 1 — BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization : Monster Digital, Inc. (“MDI”), a Delaware corporation (formed in November 2010), and its subsidiary, SDJ Technologies, Inc. (“SDJ”) (collectively referred to as the “Company”), is an importer of high-end memory storage products, flash memory and action sports cameras marketed and sold under the Monster Digital brand name acquired under a long-term licensing agreement with Monster, Inc. The Company sources its products from China, Taiwan and Hong Kong. : The Company closed its initial public offering (the “Offering”) on July 13, 2016 and its common stock and warrants are now listed on the Nasdaq Capital Market under the symbols “MSDI” and “MSDIW”, respectively. The Offering generated gross proceeds of $ 9,132,750 2,025,000 4.50 2,025,000 0.01 : The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the SEC’s instructions for interim financial information. They do not include all information and footnotes necessary for a fair presentation of financial position, operating results and cash flows in conformity with U.S. GAAP for complete financial statements. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended December 31, 2016 which are included in Form 10-K filed by the Company that on March 31, 2017. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the operating results for the periods presented have been included in the interim periods. Operating results for the three and six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for other interim periods or the year ending December 31, 2017. For interim financial reporting purposes, income taxes are recorded based upon estimated annual effective income tax rates taking into consideration discrete items occurring in a quarter. The consolidated balance sheet as of December 31, 2016 is derived from the 2016 audited financial statements. : The consolidated financial statements include the accounts of MDI and SDJ. All significant intercompany transactions have been eliminated in consolidation. : The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities (including sales returns, price protection allowances, bad debts, inventory reserves, warranty reserves, and asset impairments), disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates : The Company maintains its cash in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. Management believes the Company is not exposed to any significant credit risk on its cash balances. : Accounts receivable are carried at original invoice amount less allowance for doubtful accounts. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Accounts receivable are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. Accounts receivable are considered to be past due if any portion of the receivable balance is outstanding for more than 90 days past the customer’s granted terms. The Company does not charge interest on past due balances or require collateral on its accounts receivable. As of June 30, 2017 and December 31, 2016, the allowance for doubtful accounts was approximately $ 271,000 253,000 : Inventories are stated at the lower of cost or market, with cost being determined on the weighted average cost method of accounting. The Company purchases finished goods and materials to assemble kits in quantities that it anticipates will be fully used in the near term. Changes in operating strategy, customer demand, and fluctuations in market values can limit the Company’s ability to effectively utilize all products purchased and can result in finished goods with above-market carrying costs which may cause a write-down of inventory. The Company’s policy is to closely monitor inventory levels, obsolescence and lower market values compared to costs and, when necessary, reduce the carrying amount of its inventory to its market value. As of June 30, 2017 and December 31, 2016, inventory on hand was comprised primarily of finished goods ready for sale and packaging and supplies. : Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability. Fair value is based on a hierarchy of valuation techniques, which is determined on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own market assumptions. These two types of inputs create a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Quoted prices for identical instruments in active markets. Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amount for other financial instruments, which include cash, accounts receivable and accounts payable, approximate fair value based upon their short-term nature and maturity. : Revenue is realized or realizable and earned when all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the sales price is fixed or determinable, (3) collectability is reasonably assured, and (4) products have been shipped and the customer has taken ownership and assumed the risk of loss. Distributors and retailers take full ownership of their product upon delivery and sales are fully recognized at that time. Revenue is reduced by reserves for price protection, sales returns, allowances and rebates. The Company’s reserve estimates are based upon historical data as well as projections of sales, customer inventories, market conditions and current contractual sales terms. If the Company reduces the list price of its products, certain customers may receive a credit from the Company (i.e., price protection). The Company estimates the impact of such pricing changes on a regular basis and adjusts its allowances accordingly. Amounts charged to operations for price protection are calculated based on actual price changes on individual products and customer inventory levels. The reserve is then reduced by actual credits given to these customers at the time the credits are issued. We calculate the allowance for doubtful accounts and provision for sales returns and rebates based on management’s estimate of the amount expected to be uncollectible or returned on specific accounts. We provide for future returns, price protection and rebates at the time the products are sold. We calculate an estimate of future returns of product by analyzing units shipped, units returned and point of sale data to ascertain consumer purchases and inventory remaining with retail to establish anticipated returns. Price protection is calculated on a product by product basis. The objective of price protection is to mitigate returns by providing retailers with credits to ensure maximum consumer sales. Price protection is granted to retailers after they have presented the Company an affidavit of existing inventory. The Company also offers market development credits (“MDF credits”) to certain of its customers. These credits are also charged against revenue. : Historically, the Company has not charged its customers for shipping and handling costs, which is a component of marketing and selling expenses. These costs totaled approximately $ 22,000 59,000 53,000 94,000 : Deferred tax assets and liabilities are determined based on the temporary differences between the financial reporting and tax basis of assets and liabilities and net operating loss carryforwards, applying enacted statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some or all of the deferred tax assets will not be realized. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more likely than not to be realized upon settlement. As of June 30, 2017 and December 31, 2016, there are no known uncertain tax positions. The Company’s policy is to classify the liability for unrecognized tax benefits as current to the extent that it is more likely than not to be realized upon settlement and to the extent that the Company anticipates payment (or receipt) of cash within one year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in the tax provision. : The Company’s memory products are sold under various limited warranty arrangements ranging from three years to five years on solid state drives and a limited lifetime warranty on all other products. Company policy is to establish reserves for estimated product warranty costs in the period when the related revenue is recognized. The Company has the right to return defective products to the manufacturer. As of June 30, 2017 and December 31, 2016, the Company has established a warranty reserve of $ 101,000 118,000 : The Company incurs costs to improve the appeal and functionality of its products. Research and development costs are charged to expense when incurred. : Basic earnings (loss) per share is calculated by dividing net earnings (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share is calculated similarly but includes potential dilution from the exercise of common stock warrants and options and conversion of debt to equity, except when the effect would be anti-dilutive. Earnings (loss) per share are computed using the “treasury stock method.” At June 30, 2017, outstanding warrants to acquire 4,224,664 2,025,000 1,405,007 794,657 16,834 378,000 325,093 19,528 2,802,430 378,000 — In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In November 2015, the FASB issued ASU No. 2015-17 , Income Taxes (Topic 740), Balance Sheet Classification of Deferred Taxes In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting (Topic 718), In January 2017, the FASB issued ASU No. 2017-01, Business Combinations – Clarifying the Definition of a Business, Other pronouncements issued by the FASB with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2017
Going Concern [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 2 — GOING CONCERN As of June 30, 2017, the Company has incurred cumulative net losses from its inception of approximately $ 36 3.9 • In the six months ended June 30, 2017, the Company raised approximately $ 419 340 200 • The Company has entered into an agreement that is intended to culminate in a merger as well as a spin-off of its camera business (see Note 3). This potential transaction is expected to result in a surviving entity that would be better capitalized. • In order to meet customers’ needs for consumer products, the Company is continuing to develop new products to complement existing products and expand overall product offerings, with the objective of increasing revenue and gross profit percentages. The Company plans on introducing additional new action sports cameras in the fourth quarter of 2017. While the Company believes it will be successful in obtaining the necessary financing to fund its operations, there are no assurances that such additional funding will be achieved and that it will succeed in its future operations. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts of liabilities that might be necessary should the Company be unable to continue in existence as a going concern.

POTENTIAL MERGER

POTENTIAL MERGER	6 Months Ended
	Jun. 30, 2017
Business Combinations [Abstract]
Business Combination Disclosure [Text Block]	NOTE 3 — POTENTIAL MERGER On July 3, 2017, the Company entered into an Agreement and Plan of Merger with Innovate Biopharmaceuticals, Inc. (“Innovate”). The Merger Agreement is filed as Exhibit 2.1 to the Company’s Form 8K filed with the Securities and Exchange Commission on July 6, 2017 and this discussion regarding the potential merger should be read in conjunction with the Merger Agreement. Under the terms of the Merger Agreement, pending stockholder approval of the transaction, the Company will merge into Innovate with Innovate surviving the merger and becoming a wholly-owned subsidiary of the Company. Subject to the terms of the Merger Agreement, at the effective time of the Merger, Innovate stockholders will receive a number of newly issued shares of the Company’s common stock determined using an exchange ratio defined in the Merger Agreement. The exchange ratio will be based on a pre-transaction valuation of $ 60 6 As a result, current securityholders of the Company would collectively own approximately 9% and Innovate securityholders would collectively own approximately 91% of the combined company on a pro-forma basis, subject to adjustment based on the Company’s net cash balance and the relative capitalization of the two companies at closing, as described more fully in the Merger Agreement. In addition, prior to the closing of the Merger, the Company currently intends to transfer all of its businesses, assets and certain liabilities not assumed by Innovate further to the Merger to a new corporation, which will be either wholly owned or substantially owned by the Company. The Company is in the process of drafting a preliminary Schedule 14A, Information Required in a Proxy Statement, to obtain the required stockholder approval for the merger transaction. There can be no assurance that such stockholder approval will be attained or that, if such stockholder approval is attained, that the merger transaction will be completed.

DEBT AND EQUITY FINANCING

DEBT AND EQUITY FINANCING	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 4 — DEBT AND EQUITY FINANCING Credit Facility In June 2015, the Company secured an accounts receivable financing facility with Bay View Funding. The contract provides for maximum funding of $ 4 factoring fee of 1.35% for the first 30 days and .45% for each 10-day period thereafter that the financed receivable remains outstanding Notes Payable During the three and six months ended June 30, 2017, the Company issued $ 340,000 The notes are convertible at the lesser of $0.75 or 75% of the average market price of the Company’s common stock during the five days prior to the merger closing and bear an interest rate of 15%. The Company has agreed to give one-year warrant coverage at 25% of the number of shares issued upon conversion. 340 200 As of June 30, 2017 and December 31, 2016, a total of $ 38,000 Promissory notes From October 2015 through March 7, 2016, the Company issued promissory notes; the notes were due and payable at the earlier of one year from the date of issuance or the closing date of the Company’s initial public offering, bore an interest rate of 15 756,000 25 389 90 3,024 672,000 672,000 4.50 15 22.5 336,000 Due to Monster, Inc . In addition to the issuance of shares of common stock and common stock purchase warrants, the Company agreed to pay Monster, Inc. $ 500,000 125,000 50,000 375,000 June 30, December 31, 2017 2016 Notes payable, convertible debt $ 38 $ 38 Convertible notes payable 340 — Total $ 378 $ 38

ACCRUED EXPENSES

ACCRUED EXPENSES	6 Months Ended
	Jun. 30, 2017
Payables and Accruals [Abstract]
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]	Accrued expenses consist of the following (in thousands): June 30, December 31, 2017 2016 Royalties $ 250 $ 125 Reserve for charges against sales 174 334 Accrued purchase orders 113 158 Deferred gain 273 — Due to customer for promotional credits 59 445 Others 547 724 Total $ 1,416 $ 1,786

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	6 Months Ended
	Jun. 30, 2017
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 6 — STOCKHOLDERS’ EQUITY Common Stock Purchase Warrants : In 2016, the Company issued warrants to acquire 3,755,100 2,025,000 1,405,007 171,000 2.00 39,392 0.0052 102,041 2.00 4,224,664 3,991,015 2017 to 2025 Restricted Shares : In August 2015, the Company issued 84,170 In August 2015, the Company issued 382,575 2,103,000 In August 2016, the Company authorized the issuance of 40,000 7 14 125,000 563 In November 2016, the Company entered into a securities purchase agreement with the selling stockholder providing for the issuance and sale to such investor of 333,333 1.50 500,000 446,000 80,000 1.15 151,515 1.65 250,000 226,000 In March 2017, the Company issued 226,000 1.50 339,000 307 116,000 1.15 133,400 112 On June 23, 2017, the Company issued 172,414 0.58 100 0.05 During the three months ended June 30, 2017, the Company issued 87,500 56,150 15,000 12,500 25,000 35,000 Also during the three months ended June 30, 2017, the Company issued 95,000 4,000 43,000 22 Preferred Stock : In March 2016, the Company issued a confidential Private Placement Memorandum (“PPM”) for a maximum of 3,000,000 a purchase price of $1.00 per share and convertible into one share of the Company’s common stock and having an 8%, noncumulative dividend. 2,802,430 2.4 622,762 622,762 4.50 134,044

STOCK OPTIONS

STOCK OPTIONS	6 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE 7 — STOCK OPTIONS In 2012, the Company’s Board of Directors approved the 2012 Omnibus Incentive Plan (the “Plan”) which allows for the granting of stock options, stock appreciation rights, awards of restricted stock and restricted stock Units, stock bonuses and other cash and stock-based performance awards. A total of 970,350 600,000 46,100 51,512 145,049 778,949 On December 23, 2015, the Company authorized restricted stock grants under its 2012 Omnibus Incentive Plan of 47,135 33,688 On the effective date of the Offering, 111,332 30,000 101,332 10,000 5,000 45,000 29,000 175,000 266,000 Also granted on the effective date of the Offering were previously approved options to acquire 86,502 4.50 69,668 In August 2016, pursuant to a services agreement and outside of the Plan, the Company granted options to acquire 38,143 The Company follows the provision of ASC Topic 718, Compensations – Stock Compensation Option Date Options Exercise Estimated Intrinsic August 2016 6,004 $ 5.00 $ 3.00 None August 2016 7,230 $ 7.00 $ 3.00 None August 2016 9,986 $ 9.00 $ 3.00 None August 2016 14,923 $ 11.00 $ 3.00 None No stock options were granted during the six months ended June 30, 2017. The Company utilizes the Black-Scholes valuation method to value stock options and recognizes compensation expense over the vesting period. The expected life represents the period that the Company’s stock-based compensation awards are expected to be outstanding. The Company uses a simplified method provided in Securities and Exchange Commission release Staff Accounting Bulletin No. 110 which averages an awards weighted average vesting period and contractual term for “plain vanilla” share options. The expected volatility was estimated by analyzing the historic volatility of similar public companies. No dividend payouts were assumed as the Company has not historically paid, and is not anticipating to pay, dividends in the foreseeable future. The risk-free rate of return reflects the weighted average interest rate offered for U.S. treasury rates over the expected life of the options. Weighted average fair value of options granted $1.70 Expected term (years) 6.0 to 10.0 Risk-free interest rate 1.21% to 1.51% Volatility 45.4% Dividend yield None Number of Weighted Weighted Aggregate Options outstanding January 1, 2017 62,934 $ 4.50 9.50 $ — Granted — — — — Forfeited (46,100) — — — Outstanding at June 30, 2017 16,834 $ 4.50 9.00 $ — Weighted Average Number of Grant Date Shares Fair Value Outstanding January 1, 2017 128,467 $ 3.87 Granted 1,094,103 1.18 Vested (622,570) 1.21 Forfeited (70,000) 3.06 Outstanding at June 30, 2017 530,000 $ 1.48 The Company recorded non-cash stock-based compensation related to stock options and restricted stock of $ 226 659 179 As of June 30, 2017, the total compensation expense related to unvested options and restricted stock not yet recognized totaled approximately $ 547,000 13

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 8 — RELATED PARTY TRANSACTIONS Borrowings : From time to time, the Company receives short-term, non-interest bearing loans from Tandon Enterprises, Inc. for the purpose of funding temporary working capital needs. For the six months ended June 30, 2016, the Company borrowed $24,000, net of repayments. The $346,100 owed to Tandon Enterprises at June 30, 2016 was converted into 76,911 In September 2015, David Clarke, the Company’s Chairman of the Board and a significant stockholder of the Company, loaned the Company $100,000 further to a promissory note bearing interest at 5 50 33,333 33,333 4.50 On June 7, 2017, GSB Holdings, Inc., a family owned company of David Clarke, the Company’s CEO and Chairman of the Board, loaned the Company $ 100,000 102,041 2.00 172,414 0.58 Restricted Shares : In November 2016, the Company issued 151,515 1.65 70,000 1.50

INCOME TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 9 — INCOME TAXES For the six months ended June 30, 2017 and 2016, there was no income tax provision recorded. The Company’s income tax provision generally consists of state income taxes currently paid or payable. The ultimate realization of the deferred tax asset is dependent upon the generation of future taxable income during the periods in which temporary differences become deductible. Due to the uncertainty surrounding the realization of these deferred tax assets, the Company has recorded a 100 Net operating loss carryforwards expire between the years 2029 and 2036. The effective income tax provision as a percentage of pre-tax loss differs from expected combined federal and state income tax of 40 Management is not aware of any uncertain tax positions and does not expect the total amount of recognized tax benefits to change significantly in the next twelve months.

CUSTOMER AND VENDOR CONCENTRATI

CUSTOMER AND VENDOR CONCENTRATIONS	6 Months Ended
	Jun. 30, 2017
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE 10 — CUSTOMER AND VENDOR CONCENTRATIONS Customers : Approximately 22 19 16 11 323,000 41 18 Vendors : Approximately 99 6,000 94

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 11 — COMMITMENTS AND CONTINGENCIES Royalty The Company entered into the initial trademark license agreement with Monster, Inc. (formerly Monster Cable Products, Inc.) effective July 7, 2010. In 2012, the agreement was amended giving the Company exclusive rights to utilize the name “Monster Digital” on memory products for a period of 25 July 7, 2035 th The royalty schedule became effective in August 2011 and was further amended in April 2012. As amended, royalties under this contract are as follows: • Years 1 (2012) and 2: Royalties on all sales excluding sales to Monster, Inc. at a rate of four (4) percent, with no minimum. • Years 3 through 6: Minimum royalty payments of $ 50,000 • Years 7 through 10: Minimum royalty payments of $ 125,000 • Years 11 through 15: Minimum royalty payments of $ 187,500 • Years 16 through 25: Minimum royalty payments of $ 250,000 Effective July 1, 2014, the royalty rate on certain products was reduced from 4 2 For the three months ended June 30, 2017 and 2016, royalty expense amounted to approximately $ 125,000 71,000 250,000 121,000 250,000 Operating Lease The Company occupied executive offices in Simi Valley, CA pursuant to a lease through January 31, 2018. Effective as of March 31, 2017, the Company terminated the lease by mutually accepted and favorable terms with the lessor. Effective April 1, 2017, the Company entered into a one year lease for warehouse space in Ontario, CA. Customer Payment Agreement In July 2015, the Company entered into an agreement with a customer under which the Company will pay the customer a total of $ 835,000 Under the terms of the agreement, there is no interest and the Company will make 12 monthly payments of $65,000 beginning in August 2015, and one final payment of $65,000 in August 2016. 57,000 In January 2017, the Company entered into an agreement with a customer under which the Company settled an amount due of $ 1.84 1.5 341,000 68,000 250,000 1.2 Legal Matters The Company is subject to certain legal proceedings and claims arising in connection with the normal course of its business. In the opinion of management, the reserve established for the three cases noted below is adequate so that the claims will have no material adverse effect on its consolidated financial position, results of operations or cash flows. On February 16, 2016, the Company received a letter from GoPro, Inc., or GoPro, alleging that the Company infringes on at least five U.S. patents held by GoPro, and requesting that the Company confirms in writing that it will permanently cease the sale and distribution of its Villain camera, along with any camera accessories, including the waterproof camera case and standard housing. The five patents specifically identified by GoPro in the letter were U.S. Patent No. D710,921: camera housing design, U.S. Patent No. D702,747: camera housing design, U.S. Patent No. D740,875: camera housing design, U.S. Patent No. D737,879: camera design and U.S. Patent No. 721,935: camera design. Based upon our preliminary review of these patents, the Company believes it has some defenses to GoPro’s allegations, although there can be no assurance that the Company will be successful in defending against these allegations or reaching a business resolution that is satisfactory to us. In addition, we have begun marketing and selling the camera under the name “Monster Vision” and phasing out the “Villain” name. We have had no correspondence from GoPro since instituting the name change. The supplier of the Company’s Villain camera has contractually represented and warranted that it owns or has paid royalties to any and all intellectual property, designs, software, hardware, packaging, components, manuals and any other portion, part or element that is or may be subject to the Villain name and the parts and accessories thereof sourced by the supplier. This supplier has contractually agreed to pay any claims, damages, or costs that the Company suffers as a result of the patent infringement or a violation of international, U.S. or state laws or regulations as detailed in the prior sentence.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2017
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 12 — SUBSEQUENT EVENTS Convertible Debt Financing On July 24, 2017, the Company entered into a Private Placement Engagement Agreement with WestPark Capital, Inc. for the purpose of raising up to $ 1,150,000 15 0.75 75 For every $2.50 in Note principal purchased, investors will receive one Warrant, exercisable for five years, to purchase shares of common stock at $2.00.

BUSINESS ACTIVITY AND SUMMARY19

BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2017
Accounting Policies [Abstract]
Public Offering [Policy Text Block]	Public Offering : The Company closed its initial public offering (the “Offering”) on July 13, 2016 and its common stock and warrants are now listed on the Nasdaq Capital Market under the symbols “MSDI” and “MSDIW”, respectively. The Offering generated gross proceeds of $ 9,132,750 2,025,000 4.50 2,025,000 0.01
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation : The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the SEC’s instructions for interim financial information. They do not include all information and footnotes necessary for a fair presentation of financial position, operating results and cash flows in conformity with U.S. GAAP for complete financial statements. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended December 31, 2016 which are included in Form 10-K filed by the Company that on March 31, 2017. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the operating results for the periods presented have been included in the interim periods. Operating results for the three and six months ended June 30, 2017 are not necessarily indicative of the results that may be expected for other interim periods or the year ending December 31, 2017. For interim financial reporting purposes, income taxes are recorded based upon estimated annual effective income tax rates taking into consideration discrete items occurring in a quarter. The consolidated balance sheet as of December 31, 2016 is derived from the 2016 audited financial statements.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation : The consolidated financial statements include the accounts of MDI and SDJ. All significant intercompany transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates : The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities (including sales returns, price protection allowances, bad debts, inventory reserves, warranty reserves, and asset impairments), disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Cash : The Company maintains its cash in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts. Management believes the Company is not exposed to any significant credit risk on its cash balances.
Receivables, Policy [Policy Text Block]	Accounts Receivable : Accounts receivable are carried at original invoice amount less allowance for doubtful accounts. Management determines the allowance for doubtful accounts by identifying troubled accounts and by using historical experience applied to an aging of accounts. Accounts receivable are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded when received. Accounts receivable are considered to be past due if any portion of the receivable balance is outstanding for more than 90 days past the customer’s granted terms. The Company does not charge interest on past due balances or require collateral on its accounts receivable. As of June 30, 2017 and December 31, 2016, the allowance for doubtful accounts was approximately $ 271,000 253,000
Inventory, Policy [Policy Text Block]	Inventories : Inventories are stated at the lower of cost or market, with cost being determined on the weighted average cost method of accounting. The Company purchases finished goods and materials to assemble kits in quantities that it anticipates will be fully used in the near term. Changes in operating strategy, customer demand, and fluctuations in market values can limit the Company’s ability to effectively utilize all products purchased and can result in finished goods with above-market carrying costs which may cause a write-down of inventory. The Company’s policy is to closely monitor inventory levels, obsolescence and lower market values compared to costs and, when necessary, reduce the carrying amount of its inventory to its market value. As of June 30, 2017 and December 31, 2016, inventory on hand was comprised primarily of finished goods ready for sale and packaging and supplies.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments : Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on the assumptions that market participants would use in pricing an asset or liability. Fair value is based on a hierarchy of valuation techniques, which is determined on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own market assumptions. These two types of inputs create a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows: Level 1: Quoted prices for identical instruments in active markets. Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The carrying amount for other financial instruments, which include cash, accounts receivable and accounts payable, approximate fair value based upon their short-term nature and maturity.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition : Revenue is realized or realizable and earned when all of the following criteria are met: (1) persuasive evidence of an arrangement exists, (2) the sales price is fixed or determinable, (3) collectability is reasonably assured, and (4) products have been shipped and the customer has taken ownership and assumed the risk of loss. Distributors and retailers take full ownership of their product upon delivery and sales are fully recognized at that time. Revenue is reduced by reserves for price protection, sales returns, allowances and rebates. The Company’s reserve estimates are based upon historical data as well as projections of sales, customer inventories, market conditions and current contractual sales terms. If the Company reduces the list price of its products, certain customers may receive a credit from the Company (i.e., price protection). The Company estimates the impact of such pricing changes on a regular basis and adjusts its allowances accordingly. Amounts charged to operations for price protection are calculated based on actual price changes on individual products and customer inventory levels. The reserve is then reduced by actual credits given to these customers at the time the credits are issued. We calculate the allowance for doubtful accounts and provision for sales returns and rebates based on management’s estimate of the amount expected to be uncollectible or returned on specific accounts. We provide for future returns, price protection and rebates at the time the products are sold. We calculate an estimate of future returns of product by analyzing units shipped, units returned and point of sale data to ascertain consumer purchases and inventory remaining with retail to establish anticipated returns. Price protection is calculated on a product by product basis. The objective of price protection is to mitigate returns by providing retailers with credits to ensure maximum consumer sales. Price protection is granted to retailers after they have presented the Company an affidavit of existing inventory. The Company also offers market development credits (“MDF credits”) to certain of its customers. These credits are also charged against revenue.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling Costs : Historically, the Company has not charged its customers for shipping and handling costs, which is a component of marketing and selling expenses. These costs totaled approximately $ 22,000 59,000 53,000 94,000
Income Tax, Policy [Policy Text Block]	Income Taxes : Deferred tax assets and liabilities are determined based on the temporary differences between the financial reporting and tax basis of assets and liabilities and net operating loss carryforwards, applying enacted statutory tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is recorded when it is more likely than not that some or all of the deferred tax assets will not be realized. The Company uses a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more likely than not to be realized upon settlement. As of June 30, 2017 and December 31, 2016, there are no known uncertain tax positions. The Company’s policy is to classify the liability for unrecognized tax benefits as current to the extent that it is more likely than not to be realized upon settlement and to the extent that the Company anticipates payment (or receipt) of cash within one year. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in the tax provision.
Guarantees, Indemnifications and Warranties Policies [Policy Text Block]	Product Warranty : The Company’s memory products are sold under various limited warranty arrangements ranging from three years to five years on solid state drives and a limited lifetime warranty on all other products. Company policy is to establish reserves for estimated product warranty costs in the period when the related revenue is recognized. The Company has the right to return defective products to the manufacturer. As of June 30, 2017 and December 31, 2016, the Company has established a warranty reserve of $ 101,000 118,000
Research and Development Expense, Policy [Policy Text Block]	Research and Development : The Company incurs costs to improve the appeal and functionality of its products. Research and development costs are charged to expense when incurred.
Earnings Per Share, Policy [Policy Text Block]	Earnings (Loss) per Share : Basic earnings (loss) per share is calculated by dividing net earnings (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings (loss) per share is calculated similarly but includes potential dilution from the exercise of common stock warrants and options and conversion of debt to equity, except when the effect would be anti-dilutive. Earnings (loss) per share are computed using the “treasury stock method.” At June 30, 2017, outstanding warrants to acquire 4,224,664 2,025,000 1,405,007 794,657 16,834 378,000 325,093 19,528 2,802,430 378,000
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements — In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). In July 2015, the FASB issued ASU 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory In November 2015, the FASB issued ASU No. 2015-17 , Income Taxes (Topic 740), Balance Sheet Classification of Deferred Taxes In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Payment Accounting (Topic 718), In January 2017, the FASB issued ASU No. 2017-01, Business Combinations – Clarifying the Definition of a Business, Other pronouncements issued by the FASB with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.

DEBT AND EQUITY FINANCING (Tabl

DEBT AND EQUITY FINANCING (Tables)	6 Months Ended
	Jun. 30, 2017
Debt Disclosure [Abstract]
Schedule of Debt [Table Text Block]	Notes payable consists of the following (in thousands): June 30, December 31, 2017 2016 Notes payable, convertible debt $ 38 $ 38 Convertible notes payable 340 — Total $ 378 $ 38

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	6 Months Ended
	Jun. 30, 2017
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]	NOTE 5 — ACCRUED EXPENSES Accrued expenses consist of the following (in thousands): June 30, December 31, 2017 2016 Royalties $ 250 $ 125 Reserve for charges against sales 174 334 Accrued purchase orders 113 158 Deferred gain 273 — Due to customer for promotional credits 59 445 Others 547 724 Total $ 1,416 $ 1,786

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	6 Months Ended
	Jun. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Activity [Table Text Block]	In 2016, the following stock option grants were made: Option Date Options Exercise Estimated Intrinsic August 2016 6,004 $ 5.00 $ 3.00 None August 2016 7,230 $ 7.00 $ 3.00 None August 2016 9,986 $ 9.00 $ 3.00 None August 2016 14,923 $ 11.00 $ 3.00 None A summary of option activity for the Plan as of June 30, 2017 and changes for the six months then ended are represented as follows: Number of Weighted Weighted Aggregate Options outstanding January 1, 2017 62,934 $ 4.50 9.50 $ — Granted — — — — Forfeited (46,100) — — — Outstanding at June 30, 2017 16,834 $ 4.50 9.00 $ —
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Weighted average fair value of options granted $1.70 Expected term (years) 6.0 to 10.0 Risk-free interest rate 1.21% to 1.51% Volatility 45.4% Dividend yield None
Nonvested Restricted Stock Shares Activity [Table Text Block]	The following table summarizes restricted share activity for the six months ended June 30, 2017: Weighted Average Number of Grant Date Shares Fair Value Outstanding January 1, 2017 128,467 $ 3.87 Granted 1,094,103 1.18 Vested (622,570) 1.21 Forfeited (70,000) 3.06 Outstanding at June 30, 2017 530,000 $ 1.48

BUSINESS ACTIVITY AND SUMMARY23

BUSINESS ACTIVITY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Apr. 30, 2017	Jul. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 23, 2017	Dec. 31, 2016	Jul. 13, 2016	Sep. 30, 2015
Significant Accounting Policies Disclosure [Line Items]
Proceeds from Issuance Initial Public Offering		$ 9,132,750
Stock Issued During Period, Shares, New Issues	116,000	2,025,000
Shares Issued, Price Per Share	$ 1.15								$ 4.50	$ 4.50
Warrants Issued During Period Value									$ 2,025,000
Warrants Issued Price Per Share									$ 0.01
Allowance for Doubtful Accounts Receivable			$ 271,000		$ 271,000			$ 253,000
Shipping, Handling and Transportation Costs			22,000	$ 59,000	53,000	$ 94,000
Extended Product Warranty Accrual, Current			$ 101,000		$ 101,000			$ 118,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					4,224,664	325,093
Offering Common Stock [Member]
Significant Accounting Policies Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					2,025,000
Preferred Stock and Bridge Loan [Member]
Significant Accounting Policies Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					1,405,007
Other Warrants [Member]
Significant Accounting Policies Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					794,657
Convertible Notes Payable [Member]
Significant Accounting Policies Disclosure [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					378,000	378,000
Common Stock [Member]
Significant Accounting Policies Disclosure [Line Items]
Shares Issued, Price Per Share							$ 0.58
Antidilutive Securities Excluded From Computation Of Net Income Per Outstanding Unit Shares						19,528
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount					16,834
Preferred Stock [Member]
Significant Accounting Policies Disclosure [Line Items]
Antidilutive Securities Excluded From Computation Of Net Income Per Outstanding Unit Shares						2,802,430

GOING CONCERN (Details Textual)

GOING CONCERN (Details Textual) - USD ($)	Aug. 14, 2017	Aug. 18, 2017	Apr. 30, 2017	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Going Concern [Line Items]
Capital Deficit				$ 3,900,000	$ 3,900,000
Accumulated Other Comprehensive Income (Loss), Net of Tax				36,000,000	36,000,000
Proceeds from Sale of Restricted Investments					36,000,000
Proceeds from Issuance of Common Stock			$ 112,000		419,000	$ 0
Proceeds from Convertible Debt				$ 340,000	$ 340,000	$ 0
Subsequent Event [Member]
Going Concern [Line Items]
Proceeds from Issuance of Common Stock	$ 200,000
Proceeds from Convertible Debt		$ 308,500

POTENTIAL MERGER (Details Textu

POTENTIAL MERGER (Details Textual) - Subsequent Event [Member] - Innovate Biopharmaceuticals, Inc. [Member] $ in Millions	Jul. 03, 2017USD ($)
Business Acquisition, Transaction Costs	$ 6
Business Acquisition, Pro Forma Information, Description	As a result, current securityholders of the Company would collectively own approximately 9% and Innovate securityholders would collectively own approximately 91% of the combined company on a pro-forma basis, subject to adjustment based on the Companys net cash balance and the relative capitalization of the two companies at closing, as described more fully in the Merger Agreement.
Innovates Business [Member]
Business Acquisition, Transaction Costs	$ 60

DEBT AND EQUITY FINANCING (Deta

DEBT AND EQUITY FINANCING (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Short-term Debt [Line Items]
Notes payable, convertible debt	$ 38	$ 38
Convertible notes payable	340	0
Total	$ 378	$ 38

DEBT AND EQUITY FINANCING (De27

DEBT AND EQUITY FINANCING (Details Textual) - USD ($)	Aug. 14, 2017	Aug. 18, 2017	Apr. 30, 2017	Sep. 30, 2016	Jul. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Jun. 30, 2017	Sep. 30, 2016	Mar. 07, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016	Dec. 31, 2015	Jul. 24, 2017	Dec. 31, 2016	Jul. 13, 2016
Short-term Debt [Line Items]
Convertible notes payable									$ 340,000			$ 340,000	$ 0
Debt Conversion, Converted Instrument, Shares Issued							33,333
Debt Instrument, Interest Rate, Stated Percentage							5.00%				15.00%
Loan Processing Fee Each Dollar											$ 0.225
Amortization of Debt Issuance Costs and Discounts												0	691,000
Conversion of related party debt into equity												100,000	0
Shares Issued, Price Per Share			$ 1.15				$ 4.50											$ 4.50
Payments to Acquire Intangible Assets															$ 500,000
Debt Conversion, Converted Instrument, Warrants or Options Issued							33,333
Proceeds from Issuance of Common Stock			$ 112,000									419,000	$ 0
Convertible Debt									340,000			340,000
Subsequent Event [Member]
Short-term Debt [Line Items]
Convertible notes payable		$ 308,500
Debt Instrument, Interest Rate, Stated Percentage																15.00%
Proceeds from Issuance of Common Stock	$ 200,000
Trade Names [Member]
Short-term Debt [Line Items]
Payments to Acquire Intangible Assets				$ 375,000		$ 50,000									$ 125,000
Convertible Notes Payable [Member]
Short-term Debt [Line Items]
Convertible notes payable									340,000			340,000
Notes Payable									$ 38,000			$ 38,000					$ 38,000
Debt Instrument, Covenant Description												The notes are convertible at the lesser of $0.75 or 75% of the average market price of the Companys common stock during the five days prior to the merger closing and bear an interest rate of 15%. The Company has agreed to give one-year warrant coverage at 25% of the number of shares issued upon conversion.
Loans Payable [Member]
Short-term Debt [Line Items]
Debt Conversion, Converted Instrument, Shares Issued					672,000
Loan Processing Fee				$ 756,000
Amortization of Debt Issuance Costs and Discounts										$ 25,000				$ 389,000
Percentage of Outstanding Promissory Notes					90.00%
Conversion of related party debt into equity					$ 3,024,000
Shares Issued, Price Per Share					$ 4.50
Conversion of Debt, Percentage of Accrued Interest Waived					15.00%
Origination of Loan to Purchase Common Stock					$ 336,000
Conversion of Debt, Percentage of Origination Fees Waived					22.50%
Debt Conversion, Converted Instrument, Warrants or Options Issued					672,000
Bay View Funding [Member]
Short-term Debt [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity								$ 4,000,000
Line of Credit Facility, Commitment Fee Description								factoring fee of 1.35% for the first 30 days and .45% for each 10-day period thereafter that the financed receivable remains outstanding

ACCRUED EXPENSES (Details)

ACCRUED EXPENSES (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Schedule Of Accrued Liabilities [Line Items]
Royalties	$ 250	$ 125
Reserve for charges against sales	174	334
Accrued purchase orders	113	158
Deferred gain	273	0
Due to customer for promotional credits	59	445
Others	547	724
Total	$ 1,416	$ 1,786

STOCKHOLDERS' EQUITY (Details T

STOCKHOLDERS' EQUITY (Details Textual) - USD ($)

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Jun. 23, 2017

May 31, 2017

Apr. 30, 2017

Mar. 31, 2017

Jan. 31, 2017

Nov. 30, 2016

Jul. 31, 2016

Jun. 30, 2016

Sep. 30, 2015

Aug. 31, 2015

Jun. 30, 2017

Jun. 30, 2017

Jun. 30, 2016

Dec. 31, 2016

Aug. 31, 2016

Jul. 13, 2016

Apr. 30, 2016

Mar. 31, 2016

Dec. 31, 2012

Class of Stock [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

3,755,100

Stock Issued During Period, Shares, New Issues

116,000

2,025,000

Proceeds from Issuance of Common Stock

$ 112,000

$ 419,000

$ 0

Convertible Preferred Stock, Terms of Conversion

a purchase price of $1.00 per share and convertible into one share of the Companys common stock and having an 8%, noncumulative dividend.

Shares Issued, Price Per Share

$ 1.15

$ 4.50

$ 4.50

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 419,000

Convertible Preferred Stock Warrants Issued upon Conversion

622,762

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

970,350

Share-based Compensation

$ 226,000

659,000

179,000

Conversion of Stock, Shares Issued

1,405,007

Stock Issued During Period, Value, New Issues

$ 133,400

Proceeds from Related Party Debt

$ 100,000

$ 100,000

$ 24,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

45,000

Conversion Debt [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Outstanding

102,041

102,041

Shares Issued, Price Per Share

$ 2

$ 2

Common Stock [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Outstanding

172,414

39,392

Stock Issued During Period, Shares, Restricted Stock Award, Gross

469,478

Shares Issued, Price Per Share

$ 0.58

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 0

Exercised Price Per Share

$ 0.0052

Proceeds from Related Party Debt

$ 100,000

Common Stock [Member] | Maximum [Member]

Class of Stock [Line Items]

Shares Issued, Price Per Share

$ 0.05

Restricted Stock [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Outstanding

171,000

171,000

Restricted Stock or Unit Expense

$ 56,150

Shares Issued, Price Per Share

$ 2

$ 2

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

40,000

Share-based Compensation

$ 7,000

$ 14,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period

29,000

87,500

622,570

Stock Based Compensation To Be Amortized

$ 43,000

Stock Based Compensation To Be Amortized Term

22 years

Restricted Stock [Member] | Product Marketing [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

15,000

Restricted Stock [Member] | Employee Severance Agreement [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

12,500

Restricted Stock [Member] | Investor Relations Firm [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

25,000

Restricted Stock [Member] | Special Committee Of Board Of Directors [Member]

Class of Stock [Line Items]

Restricted Stock or Unit Expense

$ 35,000

Restricted Stock [Member] | Employees [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

95,000

Restricted Stock or Unit Expense

$ 4,000

Series A Preferred Stock [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

134,044

Convertible Preferred Stock, Shares Issued upon Conversion

622,762

3,000,000

Sale of Stock, Number of Shares Issued in Transaction

2,802,430

Proceeds from Issuance of Private Placement

$ 2,400,000

Shares Issued, Price Per Share

$ 4.50

Trademark License Agreement [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

382,575

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 2,103,000

Board of Directors Chairman [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

84,170

Jawahar Tandon [Member] | Restricted Stock [Member]

Class of Stock [Line Items]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

125,000

Share-based Compensation

$ 563,000

IPO [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

226,000

2,025,000

Private Placement [Member]

Class of Stock [Line Items]

Proceeds from Issuance of Common Stock

$ 307,000

Shares Issued, Price Per Share

$ 1.50

Stock Issued During Period, Value, New Issues

$ 339,000

Private Placement [Member] | Board of Directors Chairman [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Restricted Stock Award, Gross

151,515

Proceeds from Issuance of Private Placement

$ 226,000

Shares Issued, Price Per Share

$ 1.65

Stock Issued During Period, Value, Restricted Stock Award, Gross

$ 250,000

Private Placement [Member] | Investor [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, New Issues

80,000

333,333

Proceeds from Issuance of Private Placement

$ 446,000

Shares Issued, Price Per Share

$ 1.15

$ 1.50

Stock Issued During Period, Value, New Issues

$ 500,000

Chief Executive Officer [Member]

Class of Stock [Line Items]

Class of Warrant or Right, Outstanding

4,224,664

4,224,664

3,991,015

Unexercised Warrant Expiry Period

2017 to 2025

STOCK OPTIONS (Details)

STOCK OPTIONS (Details) - $ / shares	1 Months Ended	6 Months Ended	12 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted	30,000	0
Exercise Price		$ 0
Estimated Fair Value of Underlying Stock			$ 1.70
August 2016 One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted		6,004
Exercise Price		$ 5
Estimated Fair Value of Underlying Stock		$ 3
August 2016 Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted		7,230
Exercise Price		$ 7
Estimated Fair Value of Underlying Stock		$ 3
August 2016 Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted		9,986
Exercise Price		$ 9
Estimated Fair Value of Underlying Stock		$ 3
August 2016 Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options Granted		14,923
Exercise Price		$ 11
Estimated Fair Value of Underlying Stock		$ 3

STOCK OPTIONS (Details 1)

STOCK OPTIONS (Details 1)	12 Months Ended
	Dec. 31, 2016$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average fair value of options granted	$ 1.70
Volatility	45.40%
Dividend yield	0.00%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	10 years
Risk-free interest rate	1.51%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 years
Risk-free interest rate	1.21%

STOCK OPTIONS (Details 2)

STOCK OPTIONS (Details 2) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	6 Months Ended		12 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Options outstanding, Beginning	62,934	62,934
Number of Options, Granted	30,000	0
Number of Options, Forfeited		(46,100)	(51,512)
Number of Options outstanding, Ending		16,834		62,934
Weighted Average Exercise Price, Beginning	$ 4.5	$ 4.5
Weighted Average Exercise Price, Granted		0
Weighted Average Exercise Price, Forfeited		0
Weighted Average Exercise Price, Ending		$ 4.5		$ 4.5
Weighted Average Remaining Contract Term (in years)		9 years		9 years 6 months
Weighted Average Remaining Contract Term, Granted (in years)		0 years
Aggregate Intrinsic Value End of the Period		$ 0		$ 0

STOCK OPTIONS (Details 3)

STOCK OPTIONS (Details 3) - $ / shares	1 Months Ended	3 Months Ended	6 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Jun. 30, 2017
Number of Shares, Granted			69,668
Number of Shares, Vested	(45,000)
Restricted Stock [Member]
Number of Shares, Outstanding	128,467		128,467
Number of Shares, Granted			1,094,103
Number of Shares, Vested	(29,000)	(87,500)	(622,570)
Number of Shares, Forfeited			(70,000)
Number of Shares, Outstanding		530,000	530,000
Weighted Average Grant Date Fair Value, Outstanding	$ 3.87		$ 3.87
Weighted Average Grant Date Fair Value, Granted			1.18
Weighted Average Grant Date Fair Value, Vested			1.21
Weighted Average Grant Date Fair Value, Forfeited			3.06
Weighted Average Grant Date Fair Value, Outstanding		$ 1.48	$ 1.48

STOCK OPTIONS (Details Textual)

STOCK OPTIONS (Details Textual) - USD ($)	1 Months Ended				3 Months Ended	6 Months Ended
	Jul. 24, 2017	Jan. 31, 2017	Aug. 31, 2016	May 31, 2016	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016	Dec. 23, 2015	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized										970,350
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized				600,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period						46,100	51,512
Share-based Compensation					$ 226,000	$ 659,000	$ 179,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		30,000				0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period						69,668
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		45,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant					145,049	145,049		778,949
David Olert [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross						86,502
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price						$ 4.50
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures		175,000
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures		$ 266,000
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			40,000
Share-based Compensation					$ 7,000	$ 14,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition						13 months
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period						1,094,103
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options					$ 547,000	$ 547,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period						70,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		29,000			87,500	622,570
Restricted Stock [Member] | Four Executives [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period						111,332
Restricted Stock [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	101,332
Restricted Stock [Member] | Omnibus Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized									47,135
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period			33,688
Restricted Stock [Member] | Director [Member] | Omnibus Incentive Plan 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		5,000				10,000
Investor [Member] | Omnibus Incentive Plan 2012 [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			38,143

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	1 Months Ended			6 Months Ended
	Mar. 31, 2017	Nov. 30, 2016	Sep. 30, 2015	Jun. 30, 2017	Jun. 30, 2016	Apr. 30, 2017	Dec. 31, 2016	Jul. 13, 2016	Mar. 07, 2016
Related Party Transaction [Line Items]
Proceeds from Related Party Debt			$ 100,000	$ 100,000	$ 24,000
Debt Instrument, Interest Rate, Stated Percentage			5.00%						15.00%
Shares Issued, Price Per Share			$ 4.50			$ 1.15		$ 4.50
Debt Conversion, Converted Instrument, Warrants or Options Issued			33,333
Due to Related Parties, Current			$ 50,000	34,000			$ 44,000
Debt Conversion, Converted Instrument, Shares Issued			33,333
Debt Conversion, Converted Instrument, Amount				$ 100,000	0
Private Placement [Member]
Related Party Transaction [Line Items]
Shares Issued, Price Per Share	$ 1.50
GSB Holdings, Inc [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Warrants or Options Issued				102,041
Debt Conversion, Converted Instrument, Shares Issued				172,414
Proceeds from Notes Payable				$ 100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 2
Debt Instrument, Convertible, Conversion Price				$ 0.58
Board of Directors Chairman [Member] | Private Placement [Member]
Related Party Transaction [Line Items]
Shares Issued, Price Per Share	$ 1.50	$ 1.65
Stock Issued During Period, Shares, Restricted Stock Award, Gross	70,000	151,515
Tandon Enterprises, Inc. [Member]
Related Party Transaction [Line Items]
Proceeds from Related Party Debt					24,000
Debt Conversion, Converted Instrument, Amount					$ 346,100
Tandon Enterprises, Inc. [Member] | Common Stock And Warrants [Member]
Related Party Transaction [Line Items]
Debt Conversion, Converted Instrument, Shares Issued				76,911

INCOME TAXES (Details Textual)

INCOME TAXES (Details Textual)	6 Months Ended
	Jun. 30, 2017
Income Taxes [Line Items]
Deferred Tax Assets Valuation Allowance Percentage	100.00%
Operating Loss Carryforwards, Expiration Period	Net operating loss carryforwards expire between the years 2029 and 2036.
Effective Income Tax Rate Reconciliation, Percent	40.00%

CUSTOMER AND VENDOR CONCENTRA37

CUSTOMER AND VENDOR CONCENTRATIONS (Details Textual) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Dec. 31, 2016
Concentration Risk [Line Items]
Accounts Payable, Current	$ 599,000		$ 268,000
Accounts Receivable, Net, Current	214,000		$ 856,000
Three Vendors [Member]
Concentration Risk [Line Items]
Accounts Payable, Current	$ 6,000
Three Vendors [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	99.00%
Sales Revenue, Net [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	22.00%	41.00%
Sales Revenue, Net [Member] | Customer Two [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	19.00%
Sales Revenue, Net [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	16.00%
Sales Revenue, Net [Member] | Customer Four [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	11.00%	18.00%
Four Customers [Member]
Concentration Risk [Line Items]
Accounts Receivable, Net, Current	$ 323,000
Two Vendors [Member] | Supplier Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage		94.00%

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2012	Dec. 31, 2016	Jul. 31, 2015
Commitments And Contingencies [Line Items]
Minimum royalty payments, Years Three through Six								$ 50,000
Minimum royalty payments, Years Seven through Ten								125,000
Minimum royalty payments, Eleven through Fifteen								187,500
Minimum royalty payments, Years Sixteen through Twenty-five								$ 250,000
Royalty rate						2.00%	4.00%
Royalty Expense		$ 125,000	$ 71,000	$ 250,000	$ 121,000
Accounts Payable, Current		599,000		599,000					$ 268,000
Accrued Royalties, Current		250,000		$ 250,000					$ 125,000
Customer Payment Agreements July 2015 [Member]
Commitments And Contingencies [Line Items]
Other Commitment										$ 835,000
Other Commitments, Description				Under the terms of the agreement, there is no interest and the Company will make 12 monthly payments of $65,000 beginning in August 2015, and one final payment of $65,000 in August 2016.
Accrued Royalties, Current		57,000		$ 57,000
Customer Payment Agreements January 2017 [Member]
Commitments And Contingencies [Line Items]
Other Commitment	$ 1,840,000
Accounts Payable, Current		$ 1,200,000		$ 1,200,000
Loss Contingency Accrual, Payments	250,000
Loss Contingency Accrual, Settlement Amount	1,500,000
Loss Contingency Accrual, Deferred Gain Loss On Settlement	341,000
Loss Contingency Accrual, Gain Loss On Settlement	$ 68,000
Trademarks [Member]
Commitments And Contingencies [Line Items]
Finite Lived Intangible Asset Expiration Date								Jul. 7, 2035
Finite-Lived Intangible Asset, Useful Life								25 years

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual) - USD ($)	1 Months Ended		3 Months Ended	6 Months Ended
	Aug. 18, 2017	Jul. 24, 2017	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016	Mar. 07, 2016	Sep. 30, 2015
Debt Instrument, Interest Rate, Stated Percentage						15.00%	5.00%
Proceeds from Convertible Debt			$ 340,000	$ 340,000	$ 0
Subsequent Event [Member]
Debt Instrument, Interest Rate, Stated Percentage		15.00%
Debt Instrument, Convertible, Conversion Price		$ 0.75
Proceeds from Convertible Debt	$ 308,500
Percentage of Average Market Value		75.00%
Description of Investors Purchase Agreement		For every $2.50 in Note principal purchased, investors will receive one Warrant, exercisable for five years, to purchase shares of common stock at $2.00.
Debt Instrument,, Convertible Debt Increased Maximum		$ 1,150,000